Company Profile

Selsym Biotech Inc
Profile last edited on: 2/24/2022

Injectable hemostatic materials
Year Founded
2019
First SBIR Year
2021
Latest SBIR Award
2021
Program Status
Active

WikiProfile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

101 Linecrest Court
Cary, NC 27518
   N/A
   N/A
   N/A
Multiple Locations:   
Congressional District:   02
County:   Wake

Public Profile

An early stage, preclinical biotech startup spun out of North Carolina State University, the principals of SelSym Biotech are working to transform hemorrhage treatment and wound care through the use of novel synthetic platelet mimetic technologies.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
---
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount Project Title
2021 1 NIH $254,878
Evaluation of stability and safety of platelet-like particles for treating bleeding after trauma

Key People / Management

  Ashley Carson Brown --

  Seema Nandi -- Senior Scientist